Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges.
Schrom J, Marquez C, Wang CY, Saxena A, Mitchell AM, Ribeiro S, Pilarowski G, Nakamura R, Rojas S, Black D, Contreras Oseguera MG, Diaz EC, Payan J, Rojas S, Jones D, Tulier-Laiwa V, Zavaleta A, Martinez J, Chamie G, Glaser C, Jacobson K, Petersen M, DeRisi J, Havlir DV.
Schrom J, et al. Among authors: ribeiro s.
PLoS One. 2023 Mar 24;18(3):e0283576. doi: 10.1371/journal.pone.0283576. eCollection 2023.
PLoS One. 2023.
PMID: 36961855
Free PMC article.